Stocks › EVH
Evolent Health Inc (EVH) stock analysis
SKIP 1% confidence · analysed Oct 1, 2026
On Oct 1, 2026, our model rated Evolent Health Inc (EVH) SKIP with 1% confidence at a price of $3.43. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 20, below 30, which is oversold territory: sellers have pushed hard recently. Oversold stocks often bounce, but they can stay weak for a while.
MACD is below its signal line, so short-term momentum is pointing down.
The price is below both its 50-day and 200-day moving averages, the classic picture of a downtrend.
Volume is only 0.3x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure: ranging / no clear structure.
The most recent swing high is $6.26 and the swing low is $2.10; traders often treat these as resistance and support.
Fundamentals
The PEG ratio is 1.93, which looks reasonably priced for its growth.
The company reports a profit margin of -24.1% and revenue growth of +46.9%.
In its latest quarter it earned $0.02 per share, which beat the $-0.02 analysts expected, with revenue +46.9% year over year.
Wall Street's average rating is 1.7 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $5.75.
The next earnings report is expected around Nov 5, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.01 (SKIP). Technicals: RSI 20.31, MACD bearish, price below SMA50. Fundamentals: PEG 1.93, margin -24.1%, revenue growth 46.9%. Financial results: YoY revenue +46.9%, last EPS surprise +200.0%, next earnings 2026-11-05. Smart Money Concepts: ranging / no clear structure. FinGPT news read: positive. Memory: 24 prior look(s); 11% of directional calls matched later price. Reference price $3.44; no trade levels (SKIP).
Past ratings for EVH
Of the last 4 directional calls on EVH, 1 pointed the right way by the most recent analysis (25%). Past calls do not guarantee future results.
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Oct 1, 2026 | SKIP | 1% | $3.43 | — | |
| Aug 31, 2026 | SKIP | 7% | $4.52 | -24.1% | |
| Aug 27, 2026 | SKIP | 7% | $4.70 | -27.0% | |
| Aug 26, 2026 | BUY | 39% | $4.91 | -30.1% | ✘ wrong direction |
| Aug 25, 2026 | WEAK SELL | 23% | $4.62 | -25.8% | ✔ right direction |
| Aug 24, 2026 | WEAK BUY | 29% | $4.69 | -26.9% | ✘ wrong direction |
| Aug 21, 2026 | WEAK BUY | 21% | $4.74 | -27.6% | ✘ wrong direction |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
FTRE · HALO · HUM · IART · ICLR · IRWD · JNJ · KMDA · LH · LLY · MDT · NRC
Frequently asked questions
Is EVH a buy right now?
As of Oct 1, 2026, our automated model rates Evolent Health Inc (EVH) SKIP with 1% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does Evolent Health Inc report earnings next?
The next earnings report is expected around Nov 5, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.